Table 2.
Correlation between the expression of Nrf2 and clinical pathological factors
| Clinical factors | Expression of Nrf2 | P value | |
|---|---|---|---|
|
| |||
| Negative group (n=69, 38.3%) | Positive group (n=111, 61.7%) | ||
| Age | non | ||
| <65 ages | 24 | 47 | |
| ≥65 ages | 45 | 64 | |
| Gender | <0.05 | ||
| Male | 53 | 65 | |
| Female | 16 | 46 | |
| Tumor volume | <0.01 | ||
| <5 cm | 36 | 27 | |
| ≥5 cm | 33 | 84 | |
| Tumor invasion depth | <0.01 | ||
| T1a, T1b, T2 | 32 | 17 | |
| T3, T4a, T4b | 37 | 94 | |
| Lymphatic metastasis | <0.05 | ||
| Yes | 35 | 74 | |
| No | 34 | 37 | |
| Staging | <0.01 | ||
| IA, IB | 28 | 21 | |
| IIA, IIB | 14 | 22 | |
| IIIA, IIIB, IIIC | 27 | 68 | |
| Lymphatic invasion | <0.05 | ||
| Yes | 51 | 92 | |
| No | 18 | 15 | |
| Differentiation | <0.01 | ||
| Differentiated type | 37 | 34 | |
| Undifferentiated type | 32 | 74 | |